Literature DB >> 15574509

Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.

Kazuhiro Shiizaki1, Shigeo Negi, Ikuji Hatamura, Toshifumi Sakaguchi, Fumie Saji, Ken Kunimoto, Masahide Mizobuchi, Ikuo Imazeki, Akira Ooshima, Tadao Akizawa.   

Abstract

The most important etiological factors of resistance to medical treatments for secondary hyperparathyroidism are the decreased contents of the vitamin D receptor (VDR) and Ca-sensing receptor (CaSR) in parathyroid cells and a severely swollen parathyroid gland (PTG) as a result of hyperplasia. The effects of direct maxacalcitol (OCT) injection into PTG in terms of these factors were investigated in this study. The PTG of Sprague-Dawley rats that were 5/6 nephrectomized and fed a high-phosphate diet were treated by a direct injection of OCT (DI-OCT) or vehicle (DI-vehicle). The changes in serum intact parathyroid hormone (PTH), Ca(2+), and phosphorus levels, in VDR and CaSR expression levels in parathyroid cells, and in Ca(2+)-PTH curves were examined. Apoptosis was analyzed by the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling method and DNA electrophoresis for PTG. DI-OCT markedly decreased serum intact PTH level, and a significant difference in this level between DI-OCT and DI-vehicle was observed. However, serum Ca(2+) and phosphorus levels did not changed markedly in both groups. The upregulations of both VDR and CaSR, the clear shift to the left downward in the Ca(2+)-PTH curve, and the induction of apoptosis after DI-OCT were observed. These findings were not observed in the DI-vehicle-treated rats. Moreover, these effects of DI-OCT were confirmed by the DI-OCT into one PTG and DI-vehicle alone into another PTG in the same rat. DI-OCT may introduce simultaneous VDR and CaSR upregulations and the regression of hyperplastic PTG, and these effects may provide a strategy for strongly suppressing PTH levels in very severe secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574509     DOI: 10.1681/ASN.2004030236

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

Review 1.  Regulation of parathyroid function in chronic kidney disease (CKD).

Authors:  Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

Review 2.  The kidney and bone metabolism: Nephrologists' point of view.

Authors:  Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.

Authors:  Kazuhiro Shiizaki; Ikuji Hatamura; Eiko Nakazawa; Manabu Ogura; Takahiro Masuda; Tadao Akizawa; Eiji Kusano
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

4.  Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.

Authors:  Shozo Yano; Keiko Suzuki; Masaaki Sumi; Akihide Tokumoto; Kazushi Shigeno; Yasutoshi Himeno; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2009-06-23       Impact factor: 2.626

Review 5.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

6.  Vitamin d receptor activators and clinical outcomes in chronic kidney disease.

Authors:  Luciana Gravellone; Maria Antonietta Rizzo; Valentina Martina; Nicoletta Mezzina; Anna Regalia; Maurizio Gallieni
Journal:  Int J Nephrol       Date:  2011-05-15

7.  Clinical significance of parathyroid intervention on CKD-MBD management.

Authors:  Hiroaki Ogata; Masahide Mizobuchi; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  NDT Plus       Date:  2008-08

8.  New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.

Authors:  Noritaka Onoda; Masafumi Fukagawa; Yoshihiro Tominaga; Masafumi Kitaoka; Tadao Akizawa; Fumihiko Koiwa; Takatoshi Kakuta; Kiyoshi Kurokawa
Journal:  NDT Plus       Date:  2008-08

9.  Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.

Authors:  Shunsuke Goto; Hirotaka Komaba; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-08

10.  Cellular changes following direct vitamin D injection into the uraemia-induced hyperplastic parathyroid gland.

Authors:  Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Eiko Nakazawa; Ryoko Tozawa; Sayoko Izawa; Tadao Akizawa; Eiji Kusano
Journal:  NDT Plus       Date:  2008-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.